Issue link: https://viewer.e-digitaledition.com/i/205083
speCial CliniCal seCtion: GASTRoeNTeRoloGY five syringes, each containing 60 cc of transplant material. After sedating the patient, Dr. Brandt guides a colonoscope through the anus and rectum and into the colon. When the scope approaches the cecum, he injects the transplant matter through the instrument's accessory channel into the cecum. Following the procedure, Dr. Brandt ensures patients hold the stool for at least four hours to allow the donor bacteria the chance to take up residence in the recipient's colon. Results can be seen within a few hours, but they more typically become apparent within six days — a timeframe similar to that of antibiotic treatment. If results replicate "We are coming to appreciate much more about the extent to which the intestinal microbiota regulates and influences our health. We once considered stool a waste product but now see it as a thriving, complex ecosystem and important determinant of health." — Lawrence J. Brandt, mD, maCG, aGa-F, FaSGE, Professor of medicine and Surgery at albert Einstein College of medicine, Emeritus Chief of Gastroenterology at montefiore medical Center Stool suspension being filtered through gauze and into a canister 18 | Lower Hudson/Bronx MD News ■ MDNeWS.CoM that of antibiotic treatment, which is unquestionably less invasive, then why resort to this modality? "The advantages are that it's incredibly effective and you don't use antibiotics to alter the microbiota — meaning you're not, in a sense, maintaining the very problem that caused the C. diff infection in the first place: an altered intestinal microbiome," Dr. Brandt says. "When you administer antibiotics such as metronidazole and vancomycin to kill C. diff, you kill good and bad bacteria, not just C. diff." Screening for Disease A thorough preoperative screening process helps ensure no diseases are transmitted by FMT. Physicians screen each donor's blood for hepatitis A, B and C, syphilis, and human immunodeficiency virus, and then take a culture of the stool and conduct an ova and parasites exam, during which they also screen for the toxin that C. diff produces to damage the colon. "Since we're using someone else's microbiota and replacing the patients' bacteria with the donor's, there's the potential to expose the recipient to one or all diseases that the donor microbiota might cause the donor to develop," Dr. Brandt explains. "Although we have no proof of that, it's a theoretical concern that warrants our attention." Recipients are also screened, but primarily to establish a baseline reading for preexisting diseases. If new diseases show up after the transplant, physicians will know whether the recipient had the specific illness prior to FMT. Unlike blood transfusions, fecal matter doesn't have to match types or human leukocyte antigen, but that doesn't mean anyone can donate. "It is like blood transfusion in the sense that we're transplanting a vital body secretion," Dr. Brandt says. "You have to take precautions. In terms of donors, there are certain historical questions we ask — it's not a matter of dragging someone off the street and just using their stool." During a comprehensive patient history, Dr. Brandt elucidates important information. Ideal candidates: Stool being drawn up into syringes

